Bogart Wealth LLC’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-80
Closed -$759 – 1516
2025
Q1
$759 Sell
80
-107
-57% -$1.34K ﹤0.01% 1213
2024
Q4
$3.08K Hold
187
– – ﹤0.01% 1010
2024
Q3
$2.76K Hold
187
– – ﹤0.01% 924
2024
Q2
$2.59K Hold
187
– – ﹤0.01% 892
2024
Q1
$2.94K Hold
187
– – ﹤0.01% 856
2023
Q4
$3.03K Hold
187
– – ﹤0.01% 839
2023
Q3
$2.3K Hold
187
– – ﹤0.01% 863
2023
Q2
$3K Hold
187
– – ﹤0.01% 823
2023
Q1
$3.26K Buy
+187
New +$2.66K ﹤0.01% 816

Other funds holding NEO

Bogart Wealth LLC's NEO Position: Q2 2025 in Review

Bogart Wealth LLC sold out of NeoGenomics (NEO) in Q2 2025, closing a stake of 80 shares — an estimated $759 sold.

Bogart Wealth LLC first reported a position in NEO in Q1 2023 and held it in 9 quarters. The position peaked at $3.26K in Q1 2023. 274 funds tracked by Wall St. Rank hold NEO as of Q2 2025.

  • Bogart Wealth LLC reported no remaining NeoGenomics position as of Q2 2025 after selling out during the quarter.
  • Bogart Wealth LLC sold 80 NeoGenomics shares in Q2 2025, an estimated $759.
  • Bogart Wealth LLC first reported a position in NeoGenomics in Q1 2023 and held it in 9 quarters.
  • Bogart Wealth LLC's NeoGenomics position peaked at $3.26K in Q1 2023.
  • 274 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2025.

Based on Bogart Wealth LLC's 13F filing for Q2 2025, filed 30 Jul 2025.